Physician profile
Amy Long
NPI 1518528785
$671.24
in general payments reported to CMS, 2019-2025
19 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.80 · 2023: $96.90 · 2024: $68.34 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $77.29 | 2025 | |
| Sumitomo Pharma America, INC. | $72.01 | 2025 | Gemtesa |
| Lilly USA, LLC | $70.53 | 2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $64.88 | 2025 | Shingrix, Arexvy |
| Axonics, INC. | $49.25 | 2023 | Bulkamid, Axonics |
| Abbvie INC. | $47.65 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $35.54 | 2025 | Airsupra |
| Novo Nordisk INC | $32.63 | 2025 | Rybelsus, Ozempic |
| Melinta Therapeutics, LLC | $32.38 | 2024 | Orbactiv, Kimyrsa |
| Ibsa Pharma INC. | $24.35 | 2025 | Licart, Tirosint, Flector |
| Bayer Healthcare Pharmaceuticals INC. | $23.68 | 2025 | |
| Abbott Laboratories | $22.57 | 2025 | Freestyle Libre 3 |
| Purdue Pharma L.P. | $20.55 | 2024 | Nalmefene Hydrochloride |
| Ossur Americas, INC. | $17.97 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.67 | 2025 | Jardiance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rare Disease Therapeutics, INC. | $15.80 | 2022 | |
| Astellas Pharma US INC | $15.68 | 2025 | Veozah |
| Grifols USA, LLC | $15.41 | 2024 | Hyperrab |
| Exact Sciences Corporation | $15.40 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.